Exactech Broadens Equinoxe® Shoulder System Development With Introduction Of Resurfacing Humeral Head
March 07 2014 - 10:30AM
Business Wire
Fastest Growing Shoulder System Continues to
Drive Exactech’s Growth
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, shoulder, spine and
biologic materials, announced today successful first surgeries
using the company’s new Equinoxe® Resurfacing Humeral Head, which
expands Exactech’s Equinoxe® Platform Shoulder System.
“The Resurfacing Head broadens the Equinoxe shoulder line and
gives surgeons the ability to address the continuum of care for
shoulder arthroplasty – from early intervention to the most complex
revisions. Having a complete shoulder system also creates
contractual advantages with hospital systems around the world and
should help us maintain our status as the fastest growing shoulder
system,” said Darin Johnson, VP of Marketing, Extremities and Hips,
at Exactech.
Exactech designed the Resurfacing Humeral Head in collaboration
with surgeon consultants including Pierre-Henri Flurin, MD, Curtis
Noel, MD, Felix “Buddy” Savoie, MD, Ryan Simovitch, MD, Thomas W.
Wright, MD, and Joseph D. Zuckerman, MD. Together, they created
low-profile instrumentation designed to facilitate seamless
transitions between surgical steps; the anatomic sizing of the
device is designed to prevent overstuffing of the joint and aid in
restoring the patient’s own unique humeral head anatomy.
After completing the first surgery, Curtis Noel, MD, said, “This
case was smooth and surgeon friendly. We all agreed that it was
important to design an implant that would easily adapt to most any
anatomy, including difficult deformities, and it accomplished that
goal today. We designed a system of humeral heads to minimize the
amount of humeral reaming and added initial biologic fixation while
being ever mindful to keep it revision friendly.”
Ryan Simovitch, MD, added, “Because each patient has unique
pathology and anatomy, precision is critical when resurfacing the
shoulder. This is why we developed a system that allows all steps
-- from bone preparation to prosthetic implantation -- to be
performed over a single threaded guide-wire, thus minimizing the
risk of malpositioning. This new device will transform how I treat
challenging deformities and younger arthritic patients.”
Buddy Savoie, MD, offered, “I implanted the prosthesis through
the rotator interval without ever violating the integrity of the
subscapularis, and it was a quick, efficient procedure. The modular
design and low-profile instrumentation facilitated implantation
through a cuff-preserving approach, leaving the subscapularis
essentially intact. Having a new surgical option to treat younger
arthritic patients with a less invasive approach may lead to
speedier recovery and quicker rehab for more active patients.”
The Equinoxe system’s success in meeting surgeon and patient
needs has made it the fastest growing shoulder replacement system
in the U.S. for several years.
Surgeons can learn more about the entire Equinoxe system
including the new Resurfacing Humeral Head at Exactech’s
educational exhibit, Booth #2261, during the American Academy of
Orthopaedic Surgeons 2014 Annual Meeting, March 12 – 14 in New
Orleans. More information about all the new Exactech innovations is
available at http://www.exac.com/academy.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
Hawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888exactech@hawkassociates.comorJody Phillips,
352-377-1140Chief Financial Officer
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Sep 2023 to Sep 2024